SCHEMBL19377148

SCHEMBL19377148

COc1ccc(C(C)NC(=O)Nc2ccc(S(=O)(=O)Nc3ccc4c(c3)CCN(C(C)=O)C4)cc2)c(Cl)c1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRIM24 O15164 8/20 0.44
▸ KCNA1 Q09470 4/20 0.44
▸ KCNAB1 Q14722 4/20 0.44
▸ LMNA P02545 3/20 0.43
▸ MAPK1 P28482 2/20 0.42
▸ HTT P42858 2/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ ALDH1A1 P00352 3/20 0.41
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ DRD2 P14416 1/20 0.40
▸ HTR2A P28223 1/20 0.40
▸ HTR2C P28335 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ DRD3 P35462 1/20 0.40
▸ HTR6 P50406 1/20 0.40
▸ HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19377150 1.00 TRIM24 (0.44) TRIM24KCNA1KCNAB1LMNAMAPK1
SCHEMBL19377098 0.91 DRD2 (0.49) TRIM24KCNA1KCNAB1LMNAMAPK1
SCHEMBL19377102 0.91 DRD2 (0.49) TRIM24KCNA1KCNAB1LMNAMAPK1
SCHEMBL19377120 0.89 LMNA (0.41) TRIM24KCNA1KCNAB1LMNAMAPK1
SCHEMBL19377122 0.89 LMNA (0.41) TRIM24KCNA1KCNAB1LMNAMAPK1
SCHEMBL19377389 0.89 ABCB1 (0.43) TRIM24KCNA1KCNAB1LMNAMAPK1
SCHEMBL19377390 0.89 ABCB1 (0.43) TRIM24KCNA1KCNAB1LMNAMAPK1
SCHEMBL19377117 0.87 ACACB (0.40) TRIM24KCNA1KCNAB1ALDH1A1CYP2C9
SCHEMBL19377118 0.87 ACACB (0.40) TRIM24KCNA1KCNAB1ALDH1A1CYP2C9
SCHEMBL19377509 0.83 PNMT (0.43) LMNAMAPK1HTTALOX15SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US claimed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof UTS2R, GHSR, GRPR TRIM24 4395/4885KCNA1 4711/4885KCNAB1 4197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback